Harpeth Capital is pleased to announce that it served as financial advisor to PharmMD Solutions, LLC on a private placement of growth equity from The Riverside Company and FCA Venture Partners, IV.

"Harpeth Capital proved to be an excellent advisor during our capital raise," said Samuel "Bo" Bartholomew, Co-Founder and CEO of PharmMD. "They positioned the Company well in the market and delivered the right partners in The Riverside Company and FCA Venture Partners, IV. We are very pleased with the process and intend to grow PharmMD into the industry leader in Medication Therapy Management."

Our Client:
Based in Brentwood, Tennessee, PharmMD is the nation's leading provider of MTM software and services. The Company prevents medication-related problems through the application of the best pharmacist and physician knowledge. PharmMD improves coordination and communication among physicians, pharmacists, payers and patients by analyzing pharmacy and medical claims information and impacting clinical decision making. Because PharmMD focuses exclusively on MTM, the Company is able to analyze both aggregate and patient-specific data to identify trends and conflicts to positively impact patient health and contain costs.